More PRNewswire
View Older Stories View Newer Stories-
Seven Bridges Wealth Advisors Launches As Full-Service Independent Firm
-
Brightstar Lottery Announces Filing of Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
-
Instacart CEO to Participate in Fireside Chat at Morgan Stanley Conference
-
Danaher Announces Quarterly Dividend
-
ASUR ANNOUNCES 4Q25 RESULTS
-
Best AI Domain Generator (2026): Network Solutions Named Leading AI Domain Name Generator for Businesses by Expert Consumers
-
Following Successful Fluid Qualification Chemours & 2CRSi Join Forces to Accelerate Deployment of Two-Phase Liquid Cooling for High-Density Servers & IT Equipment
-
Simmons First National Corporation Declares $0.215 Per Share Dividend
-
Encompass Health recognized for corporate excellence on Fortune and Forbes 2026 lists
-
Energy Services of America Corporation Announces Closing of Overallotment Option and Issuance of 261,000 Shares of Common Stock
-
Health In Tech Appoints Former SAP and IBM Executive Sri Rajagopalan as Chief Technology Officer to Advance AI-driven Enterprise-Grade Platform Growth
-
Hormel Foods Appoints Donald Monk as Company's First Chief Technology Officer
-
Cboe to Present at the Raymond James Institutional Investors Conference on March 2
-
Ideal Power Business Update Webcast Call on February 26, 2026
-
In HelloNation, Cremation Services Expert Matthew T. Cup Explains Why Some Families Choose That Option
-
Caribbean Calling: Puerto Rican Pride Shines with Historic Opening of First Ideal Church of Scientology in the Islands
-
Jonathan De Armas From De Armas Law Named "Attorney of the Year" by Orlando Style Magazine
-
WYNDHAM HOTELS & RESORTS ANNOUNCES PRICING OF SENIOR NOTES OFFERING
-
Warner Bros. Discovery Board of Directors Determines Revised Proposal from Paramount Skydance Could Reasonably Be Expected to Lead to a "Company Superior Proposal"
-
Unisys Announces 4Q and Full-Year 2025 Results
-
ONE Gas to Participate in UBS, Morgan Stanley and Jefferies Conferences
-
EOG Resources Reports Fourth Quarter and Full-Year 2025 Results; Announces 2026 Capital Plan
-
HOTH THERAPEUTICS ACCELERATES HT-001 TRIAL ENROLLMENT WITH NEW CLINICAL SITE AS PATIENT DEMAND INCREASES
-
In HelloNation, Roofing Expert Ryan Gonzales of Shelton, WA, Discusses Roof Lifespan
-
Talos Energy Announces Fourth Quarter and Full-Year 2025 Results
-
FAIR: Victory! DC Circuit Rejects Illegal Aliens' Bid for Tax Privacy
-
Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results
-
Arthur J. Gallagher & Co. Announces New Investor Relations Leader
-
Tradr's SNXX Surges to $650 Million in Under a Month, Setting Industry Growth Record
-
GoDaddy Inc. Reports Fourth Quarter and Fiscal Year 2025 Financial Results
-
Lucid Files Resale Prospectus Supplement
-
Lucid Announces Fourth Quarter and Full Year 2025 Financial Results
-
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance
-
Docusign Announces Timing of Fourth Quarter Fiscal 2026 Earnings Conference Call
-
MATSON, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 RESULTS; PROVIDES 2026 OUTLOOK
-
PRA Group to Present at the Raymond James 47th Annual Institutional Investors Conference on Tuesday, March 3
-
The Hanover Insurance Group, Inc. Declares Quarterly Dividend of $0.95 Per Common Share
-
Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference
-
ClearView successfully implements Equisoft's cloud-based policy administration system
-
Realty Income Announces Operating Results for the Three Months and Year Ended December 31, 2025
-
TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results
-
Danaher to Present at TD Cowen Health Care Conference
-
Gen to Present at the Morgan Stanley Technology, Media & Telecom Conference
-
Resideo Announces Fourth Quarter and Full Year 2025 Financial Results and Initiates 2026 Outlook
-
Verra Mobility Announces Fourth Quarter and Full Year 2025 Financial Results
-
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE
-
Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA)
-
Revolve Group Announces Fourth Quarter and Full Year 2025 Financial Results
-
GRAIL to Present at the TD Cowen 46th Annual Health Care Conference
-
Axon reports Q4 2025 revenue of $797 million, up 39% year over year
